Skip to content
Biodatica
Start free

Investigator

Vladimir S. Spiegelman

PENNSYLVANIA STATE UNIV HERSHEY MED CTR · funded by NCI

Companies
1

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$2.0M

Summed across those awards.

First award
Mar 5, 2024

Latest Aug 11, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Targeting extracellular vesicles in neuroblastoma

    $690k

    Aug 11, 2025NCIPENNSYLVANIA STATE UNIV HERSHEY MED CTRNIH RePORTER · 11216953 (opens the source filing in a new tab)

  2. R01

    Targeting ß-TrCP regulators to improve CRC response to chemotherapy

    $674k

    Mar 5, 2024NCIPENNSYLVANIA STATE UNIV HERSHEY MED CTRNIH RePORTER · 11049159 (opens the source filing in a new tab)

  3. R01

    Targeting ß-TrCP regulators to improve CRC response to chemotherapy

    $662k

    Mar 5, 2024NCIPENNSYLVANIA STATE UNIV HERSHEY MED CTRNIH RePORTER · 11284032 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources